304
Participants
Start Date
October 30, 2017
Primary Completion Date
January 8, 2019
Study Completion Date
August 9, 2019
MT-6548
Oral tablet
Darbepoetin alfa
Subcutaneous
Research site, Aichi
Research site, Chiba
Research site, Fukui
Research site, Fukuoka
Research site, Fukushima
Research site, Gunma
Research site, Hiroshima
Research site, Hokkaido
Research site, Hyōgo
Research site, Ibaraki
Research site, Kagoshima
Research site, Kanagawa
Research site, Kochi
Research site, Kumamoto
Research site, Kyoto
Research site, Miyagi
Research site, Nagano
Research site, Nagasaki
Research site, Nara
Research site, Niigata
Research site, Okayama
Research site, Okinawa
Research site, Osaka
Research site, Ōita
Research site, Saga
Research site, Saitama
Research site, Shiga
Research site, Shizuoka
Research site, Tokyo
Research site, Toyama
Research site, Yamanashi
Lead Sponsor
Mitsubishi Tanabe Pharma Corporation
INDUSTRY